Inventor · disambiguated record
Wenkui K. Fang
Also filed as: FANG WENKUI · FANG WENKUI K · FANG WENKUI KEN
45 granted patents·36 pending applications·284 citations·filing 2000–2023
97Inventor score
Top patents by PatentIndex Score
81 records- 0197US6534542B2(2-hydroxy)ethyl-thioureas useful as modulators of α2B adrenergic receptorsALLERGAN INC·Filed 2001·Granted Mar 18, 2003·82 cites·54 claims
- 0292US6545182B2Methods and compositions for modulating alpha adrenergic receptor activityALLERGAN SALES INC·Filed 2001·Granted Apr 8, 2003·79 cites·15 claims
- 0391US7335803B2Methods and compositions for modulating alpha adrenergic receptor activityALLERGAN INC·Filed 2001·Granted Feb 26, 2008·40 cites·3 claims
- 0490US6313172B1Methods and compositions for modulating alpha adrenergic receptor activityALLERGAN SALES INC·Filed 2000·Granted Nov 6, 2001·42 cites·10 claims
- 0587US8063231B2Methods of treating alpha adrenergic mediated conditionsFANG WENKUI K·Filed 2009·Granted Nov 22, 2011·4 cites·1 claims
- 0686US8623856B2Phenoxy-azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulatorsALLERGAN INC·Filed 2013·Granted Jan 7, 2014·4 cites·15 claims
- 0784US8329918B2Selective alpha 2B/2C agonistsNGUYEN PHONG X·Filed 2010·Granted Dec 11, 2012·7 cites·2 claims
- 0882US8071636B2Methods of treating alpha adrenergic mediated conditionsFANG WENKUI K·Filed 2009·Granted Dec 6, 2011·4 cites·17 claims
- 0981US8871755B2Alkene azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulatorsALLERGAN INC·Filed 2014·Granted Oct 28, 2014·2 cites·13 claims
- 1080US2023062049A1Methods of treating alpha adrenergic mediated conditionsALLERGAN INC·Filed 2021·Application pending·0 cites
- 1179US9849113B2Methods of treating α adrenergic mediated conditionsALLERGAN INC·Filed 2017·Granted Dec 26, 2017·1 cites·5 claims
- 1279US9040532B2Alpha adrenergic receptor modulatorsCHOW KEN·Filed 2010·Granted May 26, 2015·4 cites·14 claims
- 1377US8518932B2Oxime azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulatorsFANG WENKUI K·Filed 2011·Granted Aug 27, 2013·3 cites·14 claims
- 1476US8557853B2Aryl fluoroethyl ureas acting as alpha 2 adrenergic agentsCHOW KEN·Filed 2007·Granted Oct 15, 2013·2 cites·6 claims
- 1575US9623006B2Methods of treating α adrenergic mediated conditionsALLERGAN INC·Filed 2015·Granted Apr 18, 2017·1 cites·5 claims
- 1674US8906899B2Azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulatorsALLERGAN INC·Filed 2013·Granted Dec 9, 2014·1 cites·8 claims
- 1773US9034910B2Methods of treating alpha adrenergic mediated conditionsGIL DANIEL W·Filed 2011·Granted May 19, 2015·1 cites·17 claims
- 1873US8957061B2Azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulatorsALLERGAN INC·Filed 2014·Granted Feb 17, 2015·1 cites·15 claims
- 1973US8729062B2Benzyl azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulatorsFANG WENKUI K·Filed 2011·Granted May 20, 2014·1 cites·8 claims
- 2073US8501726B2Azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulatorsFANG WENKUI K·Filed 2011·Granted Aug 6, 2013·1 cites·8 claims
- 2171US7754768B2Methods and compositions for modulating alpha adrenergic receptor activityALLERGAN INC·Filed 2008·Granted Jul 13, 2010·0 cites·3 claims
- 2271US2020330428A1Methods of treating alpha adrenergic mediated conditionsALLERGAN INC·Filed 2019·Application pending·0 cites
- 2370US8993553B2Azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulatorsALLERGAN INC·Filed 2013·Granted Mar 31, 2015·1 cites·11 claims
- 2470US8492561B2Azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulatorsSINHA SANTOSH C·Filed 2011·Granted Jul 23, 2013·1 cites·11 claims
- 2570US7598417B2Substituted fluoroethyl ureas as alpha 2 adrenergic agentsALLERGAN INC·Filed 2008·Granted Oct 6, 2009·1 cites·21 claims
- 2669US8754066B2Phenoxy derivatives as sphingosine 1-phosphate (S1P) receptor modulatorsALLERGAN INC·Filed 2013·Granted Jun 17, 2014·1 cites·13 claims
- 2767US2018344692A1Methods of treating alpha adrenergic mediated conditionsALLERGAN INC·Filed 2018·Application pending·0 cites
- 2865US2018071260A1Methods of treating alpha adrenergic mediated conditionsALLERGAN INC·Filed 2017·Application pending·0 cites
- 2964US8697733B2Pyridine derivatives as sphingosine 1-phosphate (S1P) receptor modulatorsALLERGAN INC·Filed 2013·Granted Apr 15, 2014·0 cites·8 claims
- 3064US2014057952A1Novel oxadiazole derivatives as sphingosine 1-phosphate (s1p) receptor modulatorsALLERGAN INC·Filed 2013·Application pending·0 cites
- 3163US8735399B2Selective subtype alpha 2 adrenergic agents and methods for use thereofHEIDELBAUGH TODD M·Filed 2009·Granted May 27, 2014·0 cites·11 claims
- 3263US8492410B2Pyridine derivatives as sphingosine 1-phosphate (S1P) receptor modulatorsALLERGAN INC·Filed 2013·Granted Jul 23, 2013·0 cites·8 claims
- 3363US2025115596A1Esters of 8-methyl-8-azabicyclo[3.2.1] octan-3-yl 3-hydroxy-2-phenylpropanoateADS THERAPEUTICS LLC·Filed 2023·Application pending·0 cites
- 3463US2014213573A1Novel benzyl azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulatorsALLERGAN INC·Filed 2014·Application pending·0 cites
- 3562US2014128369A1Novel benzyl azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulatorsALLERGAN INC·Filed 2014·Application pending·0 cites
- 3661US2014371200A1Alkene azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulatorsALLERGAN INC·Filed 2014·Application pending·0 cites
- 3760US8618139B2Oxadiazole derivatives as sphingosine 1-phosphate (S1P) receptor modulatorsFANG WENKUI K·Filed 2011·Granted Dec 31, 2013·0 cites·12 claims
- 3860US8399492B2Pyridine derivatives as sphingosine 1-phosphate (S1P) receptor modulatorsFANG WENKUI K·Filed 2011·Granted Mar 19, 2013·0 cites·8 claims
- 3960US8288555B2Alkene derivatives as sphingosine 1-phosphate (S1P) receptor modulatorsFANG WENKUI K·Filed 2011·Granted Oct 16, 2012·0 cites·11 claims
- 4058US8846728B2Oxadiazole derivatives as sphingosine 1-phosphate (S1P) receptor modulatorsALLERGAN INC·Filed 2013·Granted Sep 30, 2014·0 cites·9 claims
- 4158US7884244B2Therapeutic fluoroethylcyano guanidinesALLERGAN INC·Filed 2008·Granted Feb 8, 2011·0 cites·13 claims
- 4257US2023398233A1Ocular antibody-drug conjugatesADS THERAPEUTICS LLC·Filed 2021·Application pending·0 cites
- 4357US2014057878A1Novel oxime derivatives as sphingosine 1-phosphate (s1p) receptor modulatorsALLERGAN INC·Filed 2013·Application pending·0 cites
- 4456US8609636B2Oxime derivatives as sphingosine 1-phosphate (S1P) receptor modulatorsFANG WENKUI K·Filed 2011·Granted Dec 17, 2013·0 cites·12 claims
- 4556US8183414B2N-(1-phenyl-2-arylethyl)-4,5-dihydro-2H-pyrrol-5-amine compounds as subtype selective modulators of ALPHA2B or ALPHA2B and ALPHA2C adrenoceptorsCHOW KEN·Filed 2009·Granted May 22, 2012·0 cites·8 claims
- 4656US2024216337A1Alpha2 adrenergic agonist codrugs conjugated with muscarinic agonist drugsADS THERAPEUTICS LLC·Filed 2022·Application pending·0 cites
- 4755US2015045341A1Disubstituted aryl azetidine derivatives as sphingosine-1 phosphate receptors modulatorsALLERGAN INC·Filed 2014·Application pending·0 cites
- 4854US8703797B2Condensed ring pyridine compounds as subtype-selective modulators of sphingosine-1-phosphate-2 (S1P2) receptorsALLERGAN INC·Filed 2013·Granted Apr 22, 2014·0 cites·12 claims
- 4954US8497254B2Oxadiazole derivatives as sphingosine 1-phosphate (S1P) receptor modulatorsFANG WENKUI K·Filed 2011·Granted Jul 30, 2013·0 cites·9 claims
- 5054US8486918B2Phenyl oxadiazole derivatives as sphingosine 1-phosphate (S1P) receptorFANG WENKUI K·Filed 2011·Granted Jul 16, 2013·0 cites·12 claims
Showing the top 50 of 81 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Wenkui K. Fang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →